KC

Kathy Chen

Venture investor passionate about health, sustainability, and diversity

San Francisco, California

Overview 

Kathy Chen is a Venture Partner at Ulu Ventures, with a focus on investing in impact and health-related sectors like digital health and sustainability. With a background in finance and environmental issues, she has successfully invested in companies like SuperCircle and Vaxess Technologies, demonstrating expertise in deal execution and business strategy.

Work Experience 

  • CFO

    2025 - Current

    SuperCircle is the digital infrastructure that powers circularity for the world’s leading fashion brands. Our mission is to divert 1B units of textile waste from landfills by 2030, profitably and sustainably.

SuperCircle develops a tech platform and reverse logistics system that powers circularity for retail brands.

Raised $7,000,000.00 from Radicle Impact, Blueprint Ventures, Earthshot Ventures, BBG Ventures, Lyra Ventures and Ulu Ventures.

  • Principal > Partner

    2021 - 2024

    Led health and sustainability investing at Ulu Ventures, an early stage venture fund that uses a proprietary decision-making process to analyze risk/reward trade-offs, reduce cognitive bias, and drive superior returns. The majority of Ulu portfolio companies are founded by diverse teams that include women, minority, URM and/or immigrant founders.

Ulu Ventures primarily operates as a seed-stage venture fund.

  • Board Member, Investor

    2023 - 2024

    A revolutionary all-digital sprinkler system. Fewer, more efficient heads, accurately water to the exact shape of your landscape

Internet connected digital sprinklers that save 50% of water used in landscape irrigation.

Raised $24,134,000.00 from Tamiami Angel Funds, Echo River Capital, Burnt Island Ventures, Ulu Ventures, Sage Hill Capital, Catalyst Innovation Lab, Anorak Ventures, MFV Partners, Sum Ventures and Ulu Ventures.

  • Board Observer, Investor

    2023 - 2024

    Leveraging silk-based biomaterials, Vaxess is developing a dissolvable microneedle patch for the delivery of vaccines and therapeutics. Vaxess has raised grant and venture capital funding from groups such as RA Capital Management, Engine Ventures, GHIC, Mission BioCapital, BARDA, DARPA, NIH, NSF and the Gates Foundation.

Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.

Raised $86,868,856.00 from Mission BioCapital, Engine Ventures, RA Capital Management, Global Health Investment Corporation, The Engine, Global Health Investment Corporation, RA Capital Management and Ulu Ventures.

  • Board Member, Investor

    2023 - 2024

    SuperCircle powers circularity for the world's best retail brands. Through our tech platform and reverse logistics system, SuperCircle links retail with the waste management industry to close the loop and eliminate post-consumer clothing waste.

SuperCircle develops a tech platform and reverse logistics system that powers circularity for retail brands.

Raised $7,000,000.00 from Radicle Impact, Blueprint Ventures, Earthshot Ventures, BBG Ventures, Lyra Ventures and Ulu Ventures.

  • Investor

    2023 - 2024

    Vytala offers advance solutions for gastrointestinal (GI) health by addressing nutrient deficiencies at the source and overcoming the most complex challenge of malabsorption

  • Investor

    2022 - 2024

    Banyan Infrastructure is the only end-to-end software platform that is purpose-built to simplify, scale, and streamline sustainable infrastructure finance

Banyan Infrastructure is a project finance software platform designed to standardize and accelerate sustainable infrastructure financing.

Raised $33,200,000.00 from Elemental Impact, VoLo Earth Ventures, Energize Capital, SE Ventures and Ulu Ventures.

  • Principal

    2016 - 2021

    1955 Capital is a U.S.-based venture capital firm that invests in technologies developed in the Americas and Europe that can help solve the developing world's greatest challenges in areas including energy & environment, food safety & supply, health, and sustainable manufacturing.

1955 Capital invest in advanced technologies from the Americas and Europe to solve pressing problems in developing countries.

  • Investor

    2020 - 2021

Ampaire's mission is to be the world's most trusted developer of practical, compelling electric aircraft.

Raised $11,736,395.00 from US Department of Energy and EASME - EU Executive Agency for SMEs.

  • Investor

    2018 - 2021

Nature's Fynd is a food company that makes nutritional vegan protein from a microbe.

Raised $509,559,546.00 from EDBI, Balyasny Asset Management, SoftBank Vision Fund, Hongkou, Hillhouse Investment, SK Holdings, BAM Elevate and Blackstone Group.

Articles About Kathy

Relevant Websites